GGrantIndex
Sort

51,570 grants matching autoimmune disease

Survival and potential of insulin-deficient beta cells in type 1 diabetes

$726,966
Desmond Arthur Schatz · University Of Florida · U01 · FY2022 · DK

Partial Antagonists of IRE1 RNase—‘PAIR’s—to treat Type 1 Diabetes

$726,915
Feroz R Papa · University Of California, San Francisco · U01 · FY2021 · DK

Receptor Aggregation and Its Effects

$726,913
Byron B Goldstein · Los Alamos Nat Secty-Los Alamos Nat Lab · R37 · FY2010 · GM

Personalized Immunomonitoring to Understand Juvenile Dermatomyositis

$726,898
Maria Virginia Pascual · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AR

Mechanisms driving acute and chronic kidney function decline after immune checkpoint inhibitor therapy for cancer

$726,788
Meghan E. Sise · Massachusetts General Hospital · R01 · FY2022 · DK

Structural basis of apoptotic scrambling

$726,768
Alessio Accardi · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI

Affordable oral delivery of human blood protein drugs bioencapsulated in plant cells

$726,730
Henry Daniell · University Of Pennsylvania · R01 · FY2019 · HL

RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGY

$726,685
Mary C Nakamura · University Of California, San Francisco · P30 · FY2025 · AR

Functional outcomes of inflammatory bowel disease associated variants

$726,682
Clara Abraham · Yale University · R01 · FY2023 · DK

Mechanisms driving acute and chronic kidney function decline after immune checkpoint inhibitor therapy for cancer

$726,628
Meghan E. Sise · Massachusetts General Hospital · R01 · FY2023 · DK

Novel Innate and Adaptive Immunity Pathways Lead to Human Systemic Autoimmunity

$726,556
Maria Virginia Pascual · Baylor Research Institute · U19 · FY2014 · AI

Cbfb in RORgt-regulated T cell function

$726,464
Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2025 · AI

Resource-based Center for the Advancement of Precision Medicine in Rheumatology

$726,379
Lindsey Ann Criswell · University Of California, San Francisco · P30 · FY2019 · AR

Resource-based Center for the Advancement of Precision Medicine in Rheumatology

$726,379
Lindsey Ann Criswell · University Of California, San Francisco · P30 · FY2018 · AR

Enhancing cardiovascular risk prediction in HIV using novel factors in the REPRIEVE trial

$726,319
Virginia Athena Triant · Massachusetts General Hospital · R01 · FY2025 · HL

Functional Biology Of T Cells

$726,148
Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Structure, Function and Mechanistic Analysis of LAG3

$726,102
Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI

Defining the CD4 T Cell Response to Immunization with GAD

$726,039
Helena Kristiina Reijonen · Benaroya Research Inst At Virginia Mason · DP3 · FY2012 · DK

Descriptive Studies and Record Linkage

$725,750
William Anderson · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA

Discovery and Assessment of Genetic Determinants of HCV and HIV Control

$725,722
Raymond T Chung · Massachusetts General Hospital · R01 · FY2011 · DA

Humoral And Cellular Tolerization Approaches Against Autoimmunity

$725,721
Massimo M. Trucco · Children'S Hosp Pittsburgh/Upmc Hlth Sys · U19 · FY2007 · AI

TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals

$725,395
Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2020 · AI

Development Of Drugs Acting At Adenosine Receptors

$724,885
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK

Immune Response to RBC Antigens

$724,646
Krystalyn E Hudson · Columbia University Health Sciences · R01 · FY2023 · HL

CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D

$724,605
Nora E Sarvetnick · University Of Nebraska Medical Center · R01 · FY2019 · AI